<b>Bimekizumab Pain </b><b>Outcomes </b><b>in Patients with Hidradenitis Suppurativa</b><b>: </b><b>Pooled </b><b>48-Week </b><b>Results from BE HEARD I&II Phase 3 Randomized Clinical Trials</b>
media
posted on 2025-10-15, 14:54 authored by Adis Journals on behalf of, John R. Ingram, Hideki Fujita, Alice B. Gottlieb, Hadar Lev-Tov, Errol Prens, Christopher J. Sayed, Vivian Y. Shi, Jacek C. Szepietowski, Kenzo Takahashi, John W. Frew, Jérémy Lambert, Leah Davis, Tae Oh, Robert Rolleri, Marie-Hélène Saintmard, Lauren A.V. Orenstein<p dir="ltr"><b>Article full text</b> The above Infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).</p>
